Interview: Proscia talks about digital pathology

Chief Product Officer Nathan Buchbinder recently sat down with Labiotech to discuss digital pathology and AI. He spoke to their growing impact on drug discovery and development, highlighting the role of AI in unlocking new insights and automating routine processes like quality control. He also unpacked the unique position of digital pathology in helping to advance precision medicine by optimizing both research and diagnosis.